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DimerizationCarbonic anhydrase IX (CAIX) is a zinc metalloenzyme that catalyzes the reversible hydration of CO2. CAIX is
overexpressed in many types of cancer, including breast cancer, but is most frequently absent in
corresponding normal tissues. CAIX expression is strongly induced by hypoxia and is signiﬁcantly associated
with tumor grade and poor survival. Herein, we show that hypoxia induces a signiﬁcant increase in CAIX
protein in MDA-MB-231 breast cancer cells. Using a unique mass spectrophotometric assay, we demonstrate
that CAIX activity in plasma membranes isolated fromMDA-MB-231 is correlated with CAIX content. We also
show that CAIX exists predominantly as a dimeric, high-mannose N-linked glycoprotein. While there is some
evidence that the dimeric form resides speciﬁcally in lipid rafts, our data do not support this hypothesis. EGF,
alone, did not affect the distribution of CAIX into lipid rafts. However, acute EGF treatment in the context of
hypoxia increased the amount of CAIX in lipid rafts by about 5-fold. EGF did not stimulate tyrosine
phosphorylation of CAIX, although EGFR and down-stream signaling pathways were activated by EGF.
Interestingly, hypoxia activated Akt independent of EGF action. Together, these data demonstrate that the
active form of CAIX in theMDA-MB-231 breast cancer cell line is dimeric but that neither lipid raft localization
nor phosphorylation are likely required for its dimerization or activity.Box 100245, Department of
da, Gainesville, FL 32610, USA.
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Carbonic anhydrase (CA) is a family of zinc metalloenzymes that
catalyze the reversible hydration of CO2: CO2+H2O↔HCO3−+H+. To
date, 16 isoforms have been identiﬁed inmammals, of which three are
not catalytically active (CA-RP VIII, X and XI) [1]. The 13 catalytically
active isoforms are further divided into 4 groups based on tissue
distribution and subcellular localization. CAI, II, III, VII, and XIII are
expressed in the cytosol. CAVA and CAVB are expressed in
mitochondria, but show unique tissue distribution. CAVI is the only
secreted CA and found in salivary gland of a number of mammalian
species. There are ﬁve membrane-associated CA isoforms: CAIV, CAIX,
CAXII, CAXIV and CAXV. CAXV is not found in humans.
Two CA isoforms (CAIX and CAXII) are associated with and
overexpressed in many solid tumors and cancer cell lines [2,3]. CAIX
was ﬁrst sequenced and characterized as MN/CA9 in HeLa cells by
Pastorek et al. [4]. CAIX is a transmembrane N-linked glycoprotein that
contains 422 amino acids and four distinct domains: an N-terminal
proteoglycan-like domain, a conserved extracellular catalytic domain, a
transmembrane region, and an intracellular C-terminal, cytoplasmicdomain. The activity of the catalytic domain of CAIX is nearly identical to
that of the well studied and very active cytoplasmic isoform of this
enzyme, CAII [5]. CAIX expression is mostly restricted to pre-malignant
or malignant cells, including breast cancer, and rarely in normal tissues
or benign lesions cells [6–10]. Gastric tumors are unique in that different
parts of the normal mucosa express CAIX [11,12]. CAIX expression,
which is regulated by the HIF-1 transcription factor complex, is strongly
induced by hypoxia and is signiﬁcantly associated with tumor grade,
reduced survival, and poor prognosis in breast cancer [13]. We and
others have shown that CAIX activity is associated with extracellular
acidosis [14–17]. Increased acidity is not permissive to normal cell
growth and leads in vivo to apoptosis [18]. Yet cancer cells appear to
establish a new “set-point”which allows them to tolerate an interstitial
pH of around 6.8 [19]. Work by Gatenby and Gillies suggest that this
change in set point is critical to tumor biology because acid will ﬂow
along concentration gradients from the tumor to adjacent normal tissue
causing normal cell death, disruption of the extracellular matrix,
promotion of angiogenesis, loss of immune response to tumor antigens,
and resistance to therapeutic drugs [20,21]. Because of their increased
tolerance to extracellular pH, tumor cells are readily able to colonize this
adjacent damaged normal tissue providing a mechanism for continued
invasion and growth.
Triple negative breast cancer (TNBC) is a descriptor for a subtype of
breast cancer that does not express the estrogen receptor, progesterone
receptor, or HER2 receptor [22]. However, many of these cancers
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[23]. Recent evidence has shown that the cytoplasmic domain of CAIX
possesses a tyrosine target for the EGF receptor (EGFR) kinase and
participates in the PI3 kinase signaling pathway in renal clear cell
carcinoma(RCC) [24]. The authorsproposed that CAIX translocates from
the bulk phase plasma membrane to lipid rafts to form dimers in
response to EGF stimulation and directly mediate down-stream
signaling. Lipid rafts are unique, cholesterol-rich microdomains within
the plasma membrane that sequester signaling proteins to amplify
intracellular signaling events.
In the current study, we took advantage of the constitutive
expression of EGFR and hypoxia-inducible expression of CAIX in the
MDA-MB-231 breast cancer cell line to examine the role of hypoxia and
EGF in CAIX regulation. Our studies revealed that hypoxia-induced CAIX
exists primarily in a dimeric form in the membrane and is responsible
for most of the CA activity in isolated plasma membranes. Little CAIX
resides in lipid rafts in either control or hypoxia-exposed cells indicating
its localization to lipid rafts is not required for activity. In addition, CAIX
is not phosphorylated in response to EGF, although EGF induced a 5-fold
increase in CAIX translocation to lipid rafts. Hypoxia increased Akt
phosphorylation independent of EGF action suggesting that hypoxia
engages unique mechanisms to initiate similar signaling paths. Taken
together, our data suggest that CAIX in the MDA-MB-231 cells is active
as a dimer and does not require lipid rafts or phosphorylation for either
its activity or dimerization.
2. Materials and methods
2.1. Cell culture
The MDA-MB-231 cell line was a gift from Dr. Kevin Brown
(University of Florida) and plated at a density of 8×104 cells/per
10 cm dish in 8 mL of DMEM (Gibco) containing 10% FBS (Atlanta
Biological). Cells were grown in a humidiﬁed atmosphere containing 5%
CO2 for 3 days before treatment with 100 μM desferoxamine mesylate
(DFO) or exposure to hypoxia (1% O2, 5% CO2, and balance N2) in a
humidiﬁed Modulator Incubator Chamber (MIC-101, Billups-Rothen-
berg, Inc) for 16 h. Parallel normoxic cells were incubated in a
humidiﬁed atmosphere at 37 °C in air with 5% CO2.
2.2. Plasma membrane isolation
To isolate plasma membranes, we have used a modiﬁcation of the
method published by Sennoune et al. [25]. Cells were washed three
times with Buffer A (Tris, 10 mM; EDTA, 1 mM; NaCl, 150 mM; PMSF,
1 mM; pH 7.4) and then scraped into the same buffer. After
centrifugation at 1000 ×g for 7 min, the supernatant was removed
and the pellet was resuspended in 3 mL of Buffer B (Tris, 10 mM;
EDTA, 1 mM; NaCl, 5 mM; pH 7.4) and incubated on ice for 10 min.
The cell suspension was then homogenized in a Potter Elvehjem
homogenizer with 15 up and down strokes. Cell debris was collected
by centrifugation at 500 ×g for 5 min. The supernatant was removed
and kept on ice. TwomL of Buffer B was added to the pellet which was
then re-homogenized. After centrifugation at 250 ×g for 5 min, this
second supernatant was combined with the ﬁrst supernatant. Five mL
of Buffer C (Tris, 160 mM; EDTA, 20 mM; NaI, 2 M; MgCl2, 5 mM; pH
7.4) was added to the above solution and stirred on ice for 10 min.
Twenty mL of Buffer D (Tris, 10 mM; EDTA, 1 mM; pH 7.4) was added
to the above solution. After mixing, the solution underwent
ultracentrifugation at 105,000 ×g for 45 min at 4 °C. The pellet was
washed 3 times with Buffer D. After resuspending the pellet with
homogenizing buffer (Tris, 50 mM; EGTA, 1 mM; sucrose, 250 mM;
pH 7.4), the solution was loaded on a step gradient of 20 and 40%
sucrose (20% or 40% sucrose, Tris,10 mM; EDTA, 1 mM; pH 7.4) and
centrifuged at 200 k×g for 1 h at 4 °C. The interface between the steps
(plasma membranes) was collected and resuspended in Buffer D.After centrifugation at 100 k×g for 30 min at 4 °C, the pellet was
resuspended in homogenizing buffer and kept at −80 °C. Protein
recovery was determined by a modiﬁcation of the Lowrymethod [26].
2.3. Membrane inlet mass spectrometry (MIMS) to determine CAIX
activity
An Extrell EXM-200mass spectrophotometer was used tomeasure
directly the content of CO2 through a membrane which is permeable
to CO2 but not to bicarbonate. This allows an estimation of the rate of
exchange of 18O from CO2 and bicarbonate to water at chemical
equilibrium as previously described [27]. This process is catalyzed by
and is a measure of carbonic anhydrase activity. In our plasma
membrane samples, this activity is exclusively CAIX.
2.4. CAIX oligomerization
MDA-MB-231 cells were exposed to hypoxia for 16 h. Total
membranes were isolated as previously described [28] with minor
modiﬁcations. Brieﬂy, cellswerewashed3 timeswith 5 mLKrebsRinger
Phosphate buffer (NaCl, 128 mM; KCl, 4.7 mM;MgSO4, 1.25 mM; CaCl2,
1.25 mM; sodium phosphate, 5 mM; pH, 7.4) and incubated for 10 min.
Cells were then homogenized in a Potter Elvehjem homogenizer in a
Tris–based buffer (TES1p) containing 20 mM Tris-HCl, 25 mM sucrose,
1 mM EDTA and protease inhibitor (Sigma). A total membrane fraction
was collected at 212,000 ×g. The pellet waswashed oncewith TES1 and
resuspended in TES1p. Fifty μg of total membrane protein from hypoxic
cells was denatured in 0.5% SDS in a ﬁnal volume of 30 μL for 10 min at
100 °C. The samples were brought to 60 μL with 50 mM sodium
phosphate buffer, pH 7.5, 1% NP-40 and incubated at 37 °C for
2 h. Proteins were separated on 10% polyacrylamide gels in the
presence or absence of 1% β-mecaptoethanol. Proteins were then
transferred to nitrocellulose and probed for CAIX using the M75
monoclonal antibody developed by Pastorekova et al. [29]. For
some experiments, we also used CAIX antibodies purchased from
Novus Biologicals (NB100-417). Densitometry of individual bands
in these experiments, and all other immunoblot analyses, was
performed using UnScanIt (Silk Scientiﬁc).
2.5. CAIX glycosylation
To determine CAIX glycosylation, 50 μg of total membrane protein
(or cell lysates) from hypoxic MDA MB-231 cells was denatured in
40 mMDTT/ 0.5% SDS in a ﬁnal volume of 30 μL for 10 min at 100 °C. For
N-glycosidase F digestion, the samples were brought to 60 μL in 50 mM
sodium phosphate, pH 7.5, 1% NP-40, containing 2 μL N-glycosidase
F (1000 U) ( Biolabs) and incubated at 37 °C for 2 h. For endoglycosidase
H digestion, denatured protein sampleswere brought to 60 μl in 50 mM
sodium citrate, pH 5.5, containing 2 μL endoglycosidase (1000 U)
( Biolabs) and incubated at 37 °C for 2 h. Twenty μL of 4× sample
dilution buffer was added to each of the samples which were then
loaded onto a 10% SDS-PAGE gel for protein separation followed by
western blot analysis for CAIX expression using the M75 monoclonal
antibody.
2.6. Localization of CAIX in lipid rafts
Total membranes from MDA-MB-231 cells were isolated as
described above. Five mg of total membrane protein was extracted in
1.0 mL ice-cold MBS buffer (25 mM MES and 150 mM NaCl, pH 6.5)
containing 1% Triton X-100 (TX-100) and supplemented with protease
inhibitor. The samples weremixed end-over-end for 20 min at 4 °C and
then homogenized with 10 strokes in a Dounce homogenizer. The
homogenizing ﬂask was rinsed with 0.5 mL MBS/TX-100 and added to
the extracted sample. The samples were thenmixedwith 1.5 mL of 80%
sucrose. The samples, now at 40% sucrose, were placed at the bottom of
Fig. 1. Hypoxia increases CAIX expression and activity inMDA-MB-231 cells. Panel A: Total
membranes were collected from control cells or cells exposed to DFO or hypoxia for 16 h.
Western blot analysis of CAIX expression was performed using the NB-100 antibody. This
blot is typical of at least four independent experiments. C: Control; D:DFO (desferoxamine
mesylate), H: Hypoxia. Panel B: Plasmamembraneswere isolated from control or hypoxic
cells and CAIX activity was measured by 18O exchange. These data represent duplicate
experiments.
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3.5 mL of 5% sucrose in MBS. After centrifugation at 240,000 ×g in a
Beckman SW41 rotor for 18 h, 1.0 mL fractionswere collected into tubes
containing protease inhibitor at 4 °C by upward displacement using 60%
sucrose. The fractions were mixed and 500 μL of ice-cold, 30%
tricholoroacetic acid was added to each fraction collected. The samples
weremixed and incubatedon ice for 30 min. Theproteinprecipitatewas
collected at 16,000 ×g for 10 min after which it was washed 2 times in
1 mL of ice-cold acetone. The precipitate was then dissolved in 65 μL of
0.1% SDS. Total membrane protein (100 μg) and precipitated protein
from fractions 2–13 from the sucrose gradients were resolved on a 10%
SDS-PAGE gel under reducing conditions. The proteinswere transferred
to nitrocellulosemembrane and probed for CAIX, GLUT1 (characterized
previously [30]), caveolin (Transduction Laboratories #C13630/L5), and
transferrin receptor (Alpha Diagnostics, #TFR12-M).
2.7. Phosphorylation of EGFR and Akt
MDA-MB-231 cells, grown to 50% conﬂuence in 10 cm culture
dishes, were exposed to serum-free medium overnight under
normoxic or hypoxic conditions. Recombinant EGF (rEGF, Santa
Cruz) was dissolved in 10 mM acetic acid containing 0.1% BSA at a
stock concentration of 10 μg/mL. EGF (16 nM, ﬁnal concentration) was
added to the serum-starved, control and hypoxic cells for speciﬁc
times as indicated in the ﬁgure legends. Immediately after treatment,
cells were placed on ice, washed with ice-cold PBS (10 mM sodium
phosphate salts, 120 mM NaCl, pH 7.4), and lysed in RIPA buffer [1%
NP-40, 10 mM phosphate buffer, 0.1% SDS, 150 mMNaCl, 0.5% sodium
deoxycholate, 1 mM sodium orthovanadate, 0.5 mM phenylmethyl
sulfonyl ﬂuoride (PMSF) and protease inhibitor (Roche Diagnostics),
pH, 7.4]. Cell lysates were clariﬁed by centrifugation at 16,000 ×g for
15 min at 4 °C. Protein concentration of the clariﬁed supernatants was
determined using a modiﬁcation of the Lowry assay. Proteins were
separated on an 8% PAGE gel and transferred to a nitrocellulose
membrane for western blot analysis. The following antibodies were
used in the analysis: EGFR (Cell Signaling Technology #2232); pEGFR
(Y1173: Santa Cruz Biotechnology #sc-101668); Akt1 (Sigma
#p1601); pAkt (S473) (Cell Signaling Technology #D9E); Map
kinase/Erk2 (Calbiochem #442700); pErk1/2 (Biolabs #9106).
2.8. Phosphorylation of CAIX
Cells were treated as described above from which total mem-
branes were prepared. Total membrane proteins were lysed in RIPA
buffer. Then, lysates were processed for immunoprecipitation. Brieﬂy,
lysed samples (1 mg protein) were treated with 50 μL of a 50%
suspension of protein A/G plus-agarose (Santa Cruz) for 1 h at 4 °C to
eliminate non-speciﬁc protein binding. The beads were removed by
centrifugation at 3,000 ×g for 1 min. To the precleared supernatants,
50 μL of a 50% solution of protein A/G plus-agarose beads and 3 μg of a
(goat) polyclonal antibody against CAIX (R&D Systems #AF2188)
were added and subjected to gentle end-over-endmixing overnight at
4 °C. The immune complexes were collected by centrifugation at
3,000 ×g for 5 min. Immunoprecipitates were subjected to gel
electrophoresis and blotted onto nitrocellulose membranes. Phos-
phorylated CAIX was detected with antibody against phosphotyrosine
(Santa Cruz Biotechnology, #sc-7020). Total CAIX was detected with
the M75 monoclonal antibody.
3. Results
3.1. Hypoxia increases CAIX expression and activity in MDA-MB-231
cells
Hypoxic-dependent expressionof CAIXwas investigatedbyWestern
immunoblot. By densitometric analysis, CAIX expression was increasedby 6-fold in total membranes by desferoxamine mesylate (D), an iron
chelator which mimics the effect of hypoxia, or hypoxia (H) compared
to controls (C) (Fig. 1A).Wehavepreviously shown that CAIX is theonly
membrane-associated CA inMDA-MB-231 cells [14] which allows us to
unequivocally assay CAIX activity in plasma membranes. Using 18O
isotopic exchange between CO2 and water detected by mass spectrom-
etry, we demonstrate that there is a 7-fold increase in CA activity in
plasma membranes isolated from hypoxic cells relative to controls
(Fig. 1B). This demonstrates that there is a strong correlation between
CAIX expression and activity.
3.2. Membrane-bound CAIX is a dimer
It has been suggested that CAIX in renal carcinoma cells is
translocated to lipid rafts where it forms a dimeric structure, a process
that is controlled by EGF action [24]. To investigate the oligomerization
status of CAIX in hypoxic MDA-MB-231 cells, total membranes were
analyzed by SDS-PAGE under reducing and non-reducing conditions
(Fig. 2A). Under reducing conditions, CAIX migrated as a 54/58 kDa
doublet which has been observed by many investigators [31]. Under
non-reducing conditions, CAIX migrated as a single, higher molecular
weight band which represents 90% of the CAIX pool. Taking into
consideration the activity data (Fig. 1B), we conclude that the dimeric
form of CAIX represents most of the activity in MDA-MB-231 cells. We
also investigated the glycosylation state of CAIX through endoglycosi-
dase digestion. N-glycosidase F (PNGF) releases the entire N-linked
glycanwhile endoglycosidase H (endo H) releases the glycan only if the
structure is highmannose or a hybrid form, but not a complex structure.
The 54/58 doublets were both sensitive to PNGF showing more rapid
migration of these species in SDS-PAGE gels (Fig. 2B). This indicates that
the 54 kDa protein is not a deglycosylated formof the 58 kDa protein. In
other words, the 54 kDa species may be a truncated isoform of CAIX or
the58 kDa formmaybepost-translationallymodiﬁedbymechanisms in
addition to glycosylation. Further, both formswere completely sensitive
to endo H indicating that the glycans were of high mannose structure.
3.3. CAIX activity does not require its localization to lipid rafts
Lipid rafts are microdomains within the plasma membrane that
serve as signaling platforms. These are enriched in speciﬁc lipids and
Fig. 2. Oligomerization and glycosylation of CAIX in MDA-MB-231 cells. Panel A: Total membranes were isolated fromMDA-MB-231 cells exposed to hypoxia for 16 h. Fifty μg of total
membrane protein were separated on an SDS-PAGE gel in the presence or absence of 1% β-mercaptoethanol (β-ME). CAIX expression was detected by western blotting using the
M75 monoclonal antibody. Panel B: Total membranes were isolated from MDA-MB-231 cells exposed to hypoxia for 16 h. Fifty μg of protein was digested with 2 μL N-glycosidase F
(PNGF) in the presence of absence of protease inhibitor (PI) for 2 h at 37 °C. Panel C: Cell lysates were isolated fromMDA-MB-231 cells exposed to hypoxia for 16 h. Fifty μg of protein
was treated with 2 μL endoglycosidase H (endo H) in the presence or absence of protease inhibitor (PI) for 2 h at 37 °C. CAIX expression was detected by western blotting using the
M75 monoclonal antibody. These blots represent duplicate experiments.
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associate with, these domains. We have shown that GLUT1, in 3T3-L1
adipocytes, is associated with lipid rafts [28] and show that the same
is true for GLUT1 inMDA-MB-231 cells. In Fig. 3, fractions 3 and 4 from
sucrose density gradients represent plasma membrane vesicles
derived from lipid rafts. These vesicles are resistant to disruption by
Triton X-100 (TX-100) because of the high cholesterol and sphingo-Fig. 3. Association of CAIX and GLUT1 with lipid rafts. MDA-MB-231 cells were exposed to
collected and extracted with 1% TX-100. Detergent-resistant membranes (lipid rafts) were se
as numbered at the bottom of each panel). Expression of CAIX, GLUT1, caveolin and transferr
total pool that migrates in lipid rafts. TM = total membrane fraction; Rafts = lipid raft-con
data are representative of at least triplicate experiments.lipid content of the lipid rafts. The fractions that are labeled as “TX-
100 Soluble” represent membrane proteins that were not protected
from detergent extraction. Thus, these proteins were not in lipid rafts
to begin with and were dissolved by detergent treatment. We have
used the identiﬁcation of caveolin as a marker of lipid rafts and the
transferrin receptor as a protein excluded from lipid rafts and thus
solubilized by TX-100 exposure. Neither caveolin nor transferrinnormoxic (Panel A) or hypoxia (Panel B) conditions for 16 h. Total membranes were
parated from extracted protein by ﬂotation on sucrose gradients (fractions 2 through 13
in receptor is indicated. The values to the right of the ﬁgures represent the percent of the
taining membranes; TX-100 Soluble = membrane proteins extracted by TX-100. These
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(compare Fig. 3B to A). The localization of GLUT1 to lipid rafts in
both control and hypoxic cells represents about 25% of the total pool
despite a signiﬁcant 6-fold increase in expression in response to
hypoxia. We would interpret this to mean that hypoxia does not have
a speciﬁc inﬂuence on GLUT1 localization within the plasma
membrane. CAIX was not detected in lipid rafts in control cells
(Fig. 3A), perhaps a result of the low total CAIX expression. Hypoxia
increased the total expression of CAIX by 5-fold in this experiment
(Fig. 3B) with only a small increase in the amount of CAIX associated
with lipid rafts, about 1.1% of the total CAIX pool. With a 7-fold
increase in CAIX activity in response to hypoxia (Fig. 1B), it is unlikely
that the small shift of CAIX to lipid rafts accounts for this change in
activity. Thus, lipid raft association does not to appear to play a major
role in regulating CAIX activity under hypoxic conditions.
3.4. EGF induces CAIX translocation to lipid rafts but not its
phosphorylation
We next determined the effect of EGF on CAIX distribution within
the plasma membrane. In Fig. 4A, we show only CAIX expression.
Consistent with data in Fig. 3A, little CAIX was detected in lipid rafts
from control cells. EGF, under normoxic conditions, did not cause any
translocation of CAIX to lipid rafts. Hypoxia increased the amount of
CAIX, again by only a small amount, while the combination of hypoxia
and EGF stimulation increased the amount of CAIX by 5-fold relative
to hypoxia alone. In this particular experiment, it appeared that there
was a little more CAIX in the TM fraction isolated from hypoxic cellsFig. 4. EGF-dependent localization of CAIX. Panel A: MDA-MB-231 cells were serum-
starved overnight under normoxic or hypoxic conditions and then stimulated with EGF
(16 nM) for 30 min. Total membranes were collected and then lysed with TX-100.
Detergent resistant proteins (lipid rafts) were separated from extracted proteins. CAIX
expression in each sample was detected by western blotting using the M75monoclonal
antibody. TM= total membrane fraction; Rafts= lipid raft-containingmembranes; TX-
100 Soluble = membrane proteins extracted by TX-100. Panel B: MDA-MB-231 cells
were exposed to hypoxia for 16 h and then treated with EGF (16 nM) for 30 min. Total
membranes were prepared from which lipid rafts were isolated. CAIX and caveolin
expression were detected by western blotting. TM = total membrane proteins; LR =
lipid raft containing membranes.treated with EGF. This could of course inﬂuence the amount of CAIX in
the lipid raft fraction. We repeated this experiment and conﬁrm in
Fig. 4B that CAIX expression did not change in the presence of short-
term exposure to EGF. Together these data suggest that EGF induces
CAIX translocation to lipid raft only in the context of hypoxia,
although the pool associated with lipid rafts is relatively small (about
5%) compared to the total.
Recent data suggest that EGF stimulates CAIX tyrosine phosphor-
ylation in the cytoplasmic domain in renal carcinoma cells which
leads to down-stream activation of the PI3-kinase pathway [24]. To
investigate this possibility in MDA-MB-231 cells, we ﬁrst examined
EGF-dependent autophosphorylation of the EGF receptor (EGFR).
Cells were serum-starved under hypoxic or normoxic conditions for
16 h and then stimulated with EGF (16 nM) for speciﬁc times ranging
from 10 min to 40 min. Under these conditions, we observed a time-
dependent phosphorylation of EGFR on Y1173 (Fig. 5A). The kinetics
of phosphorylation were similar for both the normoxic and hypoxic
conditions peaking between 10 and 30 min of EGF exposure.
Activation of EGFR led to down-stream phosphorylation of both Akt
(Fig. 5B) and ERK1/2 (data not shown). Interestingly, Akt phosphor-
ylation was relatively strong in hypoxic cells even in the absence of
EGF. Under the conditions of the experiment, EGF did not inﬂuence
CAIX expression (Fig. 5C).
To examine EGF-dependent phosphorylation of CAIX, cells were
exposed to hypoxia for 16 h and then 30 min with EGF. CAIX was then
immunoprecipitated with a CAIX-speciﬁc polyclonal antibody. While
there appeared to be several phosphorylated proteins in the cell
extracts (input) including those that were EGF-dependent, there were
no phosphorylation signals in the CAIX-immunoprecipitated samples
(Fig. 6). Note the non-speciﬁc detection of the heavy chain IgG
(arrow). The presence of CAIX protein in the immunoprecipitates was
veriﬁed by Western blot using the M75 monoclonal antibody. These
results indicate that CAIX is not phosphorylated on tyrosine under
hypoxic conditions or in an EGF-dependent manner in MDA-MB-231
breast cancer cells.
4. Discussion
CAIX expression is upregulated in a wide variety of human tumors
[1] under the control of the HIF cascade [32–35]. In breast cancer, CAIX
is a marker for hypoxic regions of tumors [36], is associated with poor
prognosis [37–39], and is linked to acidiﬁcation of the tumor
microenvironment [17] which favors cancer cell survival and
resistance to chemotherapeutic agents [40]. CAIX expression has
also been linked to the basal B, triple-negative phenotype [41]. We
have shown that the MDA-MB-231 cell line is a model for this
phenotype [14] and conﬁrm here that CAIX expression is induced by
an hypoxic mimic and by hypoxia, itself. We have also shown
previously that CAIX is the only expressed membrane-bound CA
isoform in this cell line [14] which allows us to unambiguously assay
for CAIX activity. We have measured endogenous CAIX activity,
directly, using a novel mass spectrometric technique. Plasma
membranes, isolated from MDA-MB-231 cells by a method speciﬁ-
cally developed for breast cancer cells [25], exhibited a 7-fold increase
in CAIX activity in response to hypoxia which correlated well with the
increased expression of CAIX in total membranes.
The selective expression of CAIX thatwe have observed inMDA-MB-
231 cells is clearly different from the expression pattern described by
Hsieh et al., also inMDA-MB-231 cells [42]. In their study, the expression
of CAXII appeared to be signiﬁcantly higher than CAIX. Further, the
authors showed that knocking down expression of CAXII decreased the
invasion andmigration capability of the cells. So the question arises as to
how the same cell line showsdifferent expression for speciﬁc proteins. It
is appreciated that cancer arises from a stepwise accumulation of
genetic changes that afford an incipient cancer cell the properties of
unlimited, self-sufﬁcient growth and resistance to normal homeostatic
Fig. 5. EGF and hypoxia dependent activation of Akt. MDA-MB-231 cells were exposed
to normoxic (C) or hypoxic (H) conditions for 16 h in the absence of serum and then
stimulated with 16nM EGF for speciﬁc times. Proteins (100 μg) from cell lysates were
separated on SDS-PAGE gels and analyzed by western blotting. Panel A represents total
and phosphorylated pools of EGFR; Panel B represents total and phosphorylated pools
of Akt; Panel C represents the total pool of CAIX. This experiment is representative of
two independent experiments.
Fig. 6. CAIX phosphorylation in response to EGF stimulation. MDA-MB-231 cells were
exposed to hypoxia or not for 16 h in the absence of serum. EGF (16nM) was added for
30 min after which total membranes were isolated. CAIX was immunoprecipitated with
an antibody generated in goat (R&D Systems, #AF2188) followed by western blotting
with an anti-phosphotyrosine antibody or the M75 mouse monoclonal antibody. C =
control, H = hypoxia. These data represent triplicate experiments.
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play a key role in the generation of genetic and phenotypic
heterogeneity in cancer cells. Recently, Masramon et al. have demon-
strated genetic drift in clonal lines originating from isolated (colon)cancer cells [44]. This indicates that genetic instability is not lost in
cultured cells and can continue to contribute to genetic and phenotypic
differences. It is logical to assume that this genetic drift is responsible for
the protein expression differences in theMDA-MB-231 cells used in our
studies and those used by Hsieh et al. That CAXII has similar properties
to CAIX isnot unexpected based on studies from thePoussegeur lab [16].
In these studies, Chiche et al. demonstrated that overexpression of CAIX
and CAXII were equally able to regulate intracellular pH in several
different cell lines. Thus our data do not detract from the ﬁnding by
Hsieh et al. that CAXII is involved in regulating migration and invasion.
It was originally proposed that CAIX could form trimers [29]. More
recent characterization reveals that CAIX can also exist as a dimer [45].
These later biochemical studies were done with soluble recombinant
forms of CAIX (containing exofacial domains) which were expressed
in insect cell expression systems which allows protein glycosylation
process. Hilvo et al. showed that approximately 50% of the CAIX
catalytic domain constructs form dimers while in constructs contain-
ing the proteoglycan-like combined with the catalytic domain, the
dimers comprised about 60% of the pool [45]. While the catalytic
domain construct could adapt both trimeric and dimeric structures,
the proteoglycan domain construct preferred the dimer structure.
This suggests that the presence of the proteoglycan domain favors
dimerization. These investigators also identiﬁed two sets of speciﬁc
sulfhydryl groups that potentially participate in forming intermolec-
ular disulﬁde bridges. The recently published crystal structure of the
soluble form of CAIX has conﬁrmed that the two catalytic domains
associate to form a dimer, stabilized by the formation of a single
intermolecular disulﬁde bond [46,47]. While the TM domain does not
appear to be required for dimerization, we hypothesized that the
extent of dimerization may be affected by its presence. Indeed, in the
MDA-MB-231 cells, dimers comprise 90% of the CAIX pool which
infers that dimers provide the majority of the CAIX activity. The equal
intensity of the 54/58 kDa doublet, which we observed on reducing
gels, might suggest that the doublet pair is linked by a disulﬁde bond
in the dimer as the dimeric species that we observed migrated as a
single band at about 119 kDa.
It was previously shown in HeLa cells that each of the proteins that
comprise the 54/58 kDa doublet of CAIX are N-linked glycosylated [4].
We show here that the same is true for CAIX in theMDA-MB-231 cells.
The oligosaccharides on both of these doublets are of high mannose
character, based on endo H sensitivity, which is atypical for plasma
membrane proteins from normal cells. However, this is not uncom-
mon in cancer cells [48] and speciﬁcally in breast cancer cells as was
shown recently [49]. In the later study, membrane proteins showed a
165Y. Li et al. / Biochimica et Biophysica Acta 1813 (2011) 159–167signiﬁcant increase in GlcNAc2Man5 structures although the complex
glycan structures with multiantennary arrangements were not
signiﬁcantly different. Like CAIX, GLUT1 has a single N-linked
glycosylation site but migrates as a broad band suggesting heteroge-
neous, complex glycosylation which is resistant to endo H digestion
[50]. Both GLUT1 and CAIX are up-regulated by hypoxia but appear to
be differentially processed in the same cell. This preference for high
mannose glycans may be an intrinsic feature of the CAIX structure as
recombinant CAIX (constructs containing either the catalytic domain,
alone, or in combination with the proteoglycan domain) expressed in
a baculovirus-insect cells or in murine cells also exhibit high mannose
glycan structures [45].
Dorai et al. demonstrated that EGF stimulates CAIX phosphor-
ylation on tyrosine 412 in the cytoplasmic domain in a renal
carcinoma cell line, SKRC-01 [24]. This phosphorylation led to the
ability of CAIX to interact with PI3-kinase. In a similar line, SKRC-
17, which does not express CAIX, the authors demonstrated that
EGF action leading to phosphorylation of Akt was more robust
when CAIX was ecoptically expressed. This infers that EGF
stimulates CAIX phosphorylation which independently activates
the EGF signaling path. However, we were unable to demonstrate
EGF-mediated CAIX phosphorylation in the MDA-MB-231 cells.
Clearly, the EGFR is expressed in MDA-MB-231 cells, is phosphor-
ylated in the presence of EGF, and initiates down-stream signaling
events. There are several reasons why we may not have observed
phosphorylation of CAIX. The EGFR is known to reside in lipid rafts
in both normal cells and cancer cells [51,52] and to mediate the
activation of down-stream signaling pathways in cancer cells when
recruited to lipid rafts [53]. In addition, cholesterol levels change
EGFR function, trafﬁcking, and activation [54,55]. Dorai et al.
demonstrated, indirectly, that phosphorylated CAIX was present in
lipid rafts which implies that EGF stimulation causes the recruit-
ment of CAIX to lipid rafts. We were unable to detect any CAIX in
lipid rafts in control cells with or without EGF but the levels of
CAIX are quite low in normoxic cells. On the other hand, if EGFR is
localized to lipid rafts, then the interaction between EGFR and CAIX
might not occur. We did observe an EGF-dependent increase in the
content of CAIX in lipid rafts under hypoxic conditions which
represented about 5% of the total CAIX pool. If this particular pool
was phosphorylated, admittedly, it might go undetected. There is
also the issue of CAIX function in renal cell carcinoma versus breast
cancer cells. CAIX in RCC is not upregulated by the condition of
hypoxia, as it is in triple negative breast cancers and MDA-MB-231
cells. Rather, mutations in the prolyl hydroxylase which normally
mediates the degradation of HIF1α drives CAIX expression. Thus
the environment surrounding RCC cells and breast cancer cells is
quite different. Further, CAIX expression in RCC is a positive
predictor of survival [6] while CAIX expression in breast cancer is
an indicator of poor prognosis [13]. How these differences play out
with respect to EGF action is not known at this point.
PTEN mutation or loss, which leads to sustained activation of
PI3-kinase, is associated with many forms of cancer, including
breast cancer [56]. However, MDA-MB-231 cells do not lack PTEN
[57] which means that the PI3-kinase pathway is not constitutively
activated. This allowed us to examine both the effect of hypoxia
and EGF on this signaling path. EGF, as expected, stimulated Akt
phosphorylation by activating EGFR. This is consistent with earlier
studies [57]. Our data also showed that hypoxia, independent of
EGFR activation, enhanced Akt phosphorylation. Others have
shown that this activation is mediated through PI3-kinase [58,59]
and leads to protection from apoptosis [58]. Further, hypoxia-
induced activation of Akt can be blocked by inhibitors of transcrip-
tion or protein synthesis, although the levels of Akt are not affected
by these treatments [58]. While preparing the present manuscript,
Mardilovich and Shaw showed that IRS2 is transcriptionally
upregulated by hypoxia in MDA-MB-231 cells [60]. Thus, the cellsare poised for activation by the IGF1 signaling system. Yet in our
experiments, serum was absent for the duration of hypoxic
treatment. Thus, IGF-mediated phosphorylation of IRS2 is not
responsible for the hypoxic activation of Akt in our setting.
Akt activation is also involved in localizing GLUT1 to the cell
surface andmaintaining hexokinase activity [61] which favors aerobic
glycolysis in tumor cells [62]. While GLUT1 is transcriptionally
upregulated by HIF1α, hypoxia-activated Akt may also help to recruit
GLUT1 to the cell surface and maintain the distribution between
intracellular membrane stores and the plasma membrane. While
there are data suggesting that lipid rafts inﬂuence GLUT1 activity
[28,63], the increase in localization of GLUT1 to lipid rafts inMDA-MB-
231 cells is equivalent to the increased expression of GLUT1 in
response to hypoxia. As well, the increase in glucose uptake in
response to hypoxia (data not shown) is equivalent to GLUT1
expression. It would seem logical to conclude that GLUT1 activity is
a reﬂection of the total pool.
In conclusion, we have shown that CAIX activity and expression
are well correlated in hypoxia-treated MDA-MB-231 cells. EGF
recruits CAIX to lipid rafts, in the context of hypoxia, but it is unlikely
that this association regulates its oligomerization status or its activity.
Further, we did not detect any EGF-dependent CAIX phosphorylation,
despite an intact EGF signaling system. Rather, hypoxia activates Akt
independently from EGF action to induce what Dorai et al. called the
vicious cycle [24]. Thus, hypoxia induces the stabilization of HIF1α
which mediates the expression of CAIX through transcriptional
activation of its gene, and increases Akt activation which enhances
cap-dependent translation of HIF1α to further induce expression of
target genes.
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